Myriad Genetics
MYGN
$18.18
Share price
1.11%
Change (1 day)
-14.20%
Change (1 year)
Myriad Genetics (MYGN) - Net assets
Net assets on the balance sheet as of December 2023 : $0.78 B
According to Myriad Genetics's latest financial reports the company has $0.78 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Myriad Genetics - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.78 B | -11.58% |
| 2022-12-31 | $0.88 B | -8.47% |
| 2021-12-31 | $0.96 B | |
| 2020-06-30 | $0.91 B | -15.68% |
| 2019-06-30 | $1.08 B | 12.71% |
| 2018-06-30 | $0.96 B | 25.79% |
| 2017-06-30 | $0.76 B | 2.66% |
| 2016-06-30 | $0.74 B | 12.99% |
| 2015-06-30 | $0.66 B | -7.91% |
| 2014-06-30 | $0.71 B | -1.32% |
| 2013-06-30 | $0.72 B | 14.62% |
| 2012-06-30 | $0.63 B | 12.15% |
| 2011-06-30 | $0.56 B | 1.65% |
| 2010-06-30 | $0.55 B | 28.41% |
| 2009-06-30 | $0.43 B | 2.01% |
| 2008-06-30 | $0.42 B | 25.06% |
| 2007-06-30 | $0.34 B | 36.26% |
| 2006-06-30 | $0.24 B | 84.11% |
| 2005-06-30 | $0.13 B | -21.7% |
| 2004-06-30 | $0.17 B | 5.99% |
| 2003-06-30 | $0.16 B | 26.86% |
| 2002-06-30 | $0.12 B | -7.66% |
| 2001-06-30 | $0.13 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $38.82 B | 4,857.48% | 🇺🇸 USA |
 Exact Sciences EXAS | $3.14 B | 301.60% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $4.95 B | 532.22% | 🇺🇸 USA |
 Biocept
BIOC | $0.29 M | -99.96% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | $8.74 B | 1,016.08% | 🇺🇸 USA |